Synthesis, Structure and Biological Activity of 2-[2-(4-Fluorobenzylidene)hydrazinyl]-4-(1-methyl-1H-indol-3-yl)thieno[3,2-d]pyrimidine

被引：2

作者：

史建涛 ^{[1
]}

宫益林 ^{[1
]}

李军 ^{[1
]}

王洋 ^{[1
]}

陈烨 ^{[1
]}

丁实 ^{[1
]}

刘举 ^{[1
]}

机构：

[1] College of Pharmacy of Liaoning University, Key Laboratory of New Drug Research and Development of Liaoning Province

来源：

ChineseJournalofStructuralChemistry | 2019年 / 38卷 / 09期

基金：

中国国家自然科学基金;

关键词：

thieno[3,2-d] pyrimidine; synthesis; X-ray diffraction; antitumor activity;

D O I：

10.14102/j.cnki.0254-5861.2011-2410

中图分类号：

TQ463 [有机化合物药物的生产];

学科分类号：

1007 ;

摘要：

The title compound 2-[2-(4-fluorobenzylidene)hydrazinyl]-4-(1-methyl-1 H-indol-3-yl)thieno[3,2-d] pyrimidine(8) was synthesized by the condensation of 4-fluorobenzaldehyde(7) with 2-hydrazinyl-4-(1-methyl-1 H-indol-3-yl)thieno[3,2-d]pyrimidine(6). This intermediate was prepared from methyl 3-aminothiophene-2-carboxylate(1) by the condensation with urea, chlorination with phosphorus oxychloride and then condensation with hydrazine hydrate. The crystal of 8 belongs to monoclinic system, space group P21/c with a = 14.0453(18), b = 17.436(2), c = 18.0982(17) ? and β = 122.969(7)°. In addition, 8 possesses marked inhibition against the proliferation of human colon cancer cell line HT-29(IC50 = 6.09 μM) and human gastric cancer cell line MKN45(IC50 = 3.04 μM), displaying promising anticancer activity.

引用

页码：1530 / 1536

页数：7

共 50 条

[21] 2-[(2E)-2-(3-chloro-2-fluorobenzylidene)hydrazinyl]pyridine: Synthesis, spectroscopic, structural properties, biological activity and theoretical analysis
Ozcelik, Nefise
Tunc, Tuncay
Celik, Raziye Catak
Erzengin, Mahmut
Ozisik, Haci
JOURNAL OF MOLECULAR STRUCTURE, 2021, 1227
[22] Synthesis and biological activities of 2-(1-aryl-3-methyl-5-chloro1H-pyrazol-4-yl)-3-(1-aroylamino)-4-thiazolidinones
Wen, LP
Li, M
Jing, SX
Cao, W
Yang, HZ
CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2005, 25 (02) : 197 - 200
[23] Synthesis, Crystal Structure and Antitumor Activity of 4-(5-(2,6-Difluorophenyl)-1,3,4-oxadiazol-2-ylthio)-2-(trifluoromethyl)thieno[2,3-d]pyrimidine
宋新建
李晨晨
王旭梅
孙琦
杨平
ChineseJournalofStructuralChemistry, 2019, 38 (08) : 1344 - 1348
[24] (S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl)propanoic acid compounds: Synthesis and biological evaluation of dual PPARα/γ agonists
Zhou, Xinbo
Chen, Wei
Xu, Cheng
Fan, Shiyong
Xie, Yunde
Zhong, Wu
Wang, Lili
Li, Song
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2605 - 2608
[25] Synthesis, Crystal Structure and Antitumor Activity of 4-(5-(2,6-Difluorophenyl)-1,3,4-oxadiazol-2-ylthio)-2-(trifluoromethyl)thieno[2,3-d]pyrimidine
Song Xin-Jian
Li Chen-Chen
Wang Xu-Mei
Sun Qi
Yang Ping
CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2019, 38 (08) : 1344 - 1348
[26] Syntheses and Crystal Structures of (S)-Methyl 2-(4-R-phenylsulfonamido)-3-(1H-indol-3-yl)propanoate (R=H(1)and Cl (2))
李文明
王建国
郭万成
李正名
宋海斌
Chinese Journal of Structural Chemistry, 2008, (06) : 691 - 696
[27] Synthesis,Crystal Structure and Biological Activity of 8-((4-((2,3-diaminopyridin-4-yl)oxy)-3-fluorophenyl)-amino)-2-(4-fluorophenyl)-3-methyl-2,7-naphthyridin-1(2H)-one
卓林胜
董欢
黄伟
赵兴俄
佘能芳
Chinese Journal of Structural Chemistry, 2014, (06) : 859 - 864
[28] Synthesis of (S)-2-(3-arylacrylamido)-3-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl}propanoic acids
Zhou, XB
Lin, CF
Li, S
CHINESE CHEMICAL LETTERS, 2005, 16 (10) : 1301 - 1304
[29] Synthesis, Crystal Structure and Biological Activity of 8-((4-((2,3-diaminopyridin-4-yl)oxy)-3-fluorophenyl)-amino)-2-(4-fluorophenyl)-3-methyl-2,7-naphthyridin-1(2H)-one
Zhuo Lin-Sheng
Dong Huan
Huang Wei
Zhao Xing-E
She Neng-Fang
CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2014, 33 (06) : 859 - 864
[30] Synthesis, spectroscopic characterization, and in vitro antimicrobial activity of fused pyrazolo[4′,3′:4,5]thieno[3,2-d]pyrimidine
Saber, Ahmed F.
Kamal El-Dean, Adel M.
Redwan, Shaban M.
Zaki, Remon M.
JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2020, 67 (07) : 1239 - 1246

← 1 2 3 4 5 →